Reported Quality Incidents
The following issues have been reported by the FIP treatment community. Where possible, testing and follow up is done to investigate and confirm the report.
These quality alerts are intended as a reminder of just how broad and unregulated the unlicenced FIP drug market is -- it is not meant to be a comprehensive report of all products or batches of products on the market. Lab testing is the only way of actually confirming what and how much of a substance they contain, but only a minuscule fraction of these products are tested. While many claims are made about the content, reliability, and efficacy of FIP treatment products, very little is known about the quality control, testing and disclosure to consumers given by the manufacturers and promoters.
Although the information listed on this site has been produced and processed from sources believed to be reliable, no warranty, express or implied, is made regarding accuracy, adequacy, completeness, legality, reliability or usefulness of any information.
Status:
Recalled. Customers should contact vendor for further info.
Mfr Product Recall - Lanzi pills
November 14, 2023
The manufacturer of Lanzi GS tablets has issued a recall for their GS tablets after supply chain adulteration was detected. GS injectables are not affected.
Vendor Response:
The vendor has notified affected customers of a product recall.
Findings:
Based on fipsafe TLC testing it appears these tablets may contain molnupiravir.
Test Results:
No test results
Recommendations:
Contact vendor and do not use these tablets.
Status:
Investigating, seeking samples for testing
Lucky 20 - Precipitation in Vials
May 28, 2023
3 reports of Lucky 20 vials received through shipping with precipitation. Precipitate went into solution in warm water bath.
10 mL vials, lime green cap
Vendor Response:
The vendor is investigating
Findings:
Test Results:
No test results
Recommendations:
Inspect vials carefully before use, and do not use if you see crystals or other signs of precipitation. Precipitation may be brought back into solution by placing in a hot water bath and agitating.
Status:
Problems found, final report is pending
Adulterated/Substituted contents in GC 2 mL vials
August 13, 2023
Some "Generic" 2 mL vials labeled as GC376 may contain GS-441524 or EIDD-2801. Testing is in progress.
2 mL vial, clear cap
Vendor Response:
The vendor is investigating supply chain issues with their bulk suppliers.
Findings:
Lab testing indicates that some vials contain GS-441524 and others may contain another antiviral (likely EIDD-2801). Final report is pending.
Test Results:
No test results
Recommendations:
At this time it is recommended not to use.
Status:
Confirmed, further testing in progress
Rainbow - Precipitation in Vials
May 28, 2023
Multiple reports of Rainbow GS vials with the contents precipitated out of solution. At least one person has reported that the GS does not go back into solution when placed in warm water bath.
Affected vials reported mostly seem to have been obtained via local pickup contacts, and may have been refrigerated.
5 mL vials, yellow cap
Vendor Response:
The vendor has acknowledged the incident and that there is a problem with the pH of Rainbow leading it to precipitate easily in colder temperatures.
Findings:
Per the vendor, changes in formulation were made, making this less shelf stable especially in colder temperatures. It does not seem to go back into solution, precipitated vials may need to be discarded.
Test Results:
No test results
Recommendations:
Inspect vials carefully before use, and do not use if you see crystals or other signs of precipitation. Do not refrigerate. Discard precipitated vials.